Soga, Yoshimitsu http://orcid.org/0000-0003-1931-5769
Fujihara, Masahiko
Yamamoto, Yoshito
Nakamura, Shigeru
Iida, Osamu
Kawasaki, Daizo
Urasawa, Kazushi
Ando, Hiroshi
Mori, Shinsuke
Suzuki, Kenji
Horie, Kazunori
Diaz-Cartelle, Juan
Kozuki, Amane
Clinical trials referenced in this document:
Documents that mention this clinical trial
One-year results for Japanese patients in RANGER II SFA
https://doi.org/10.1007/s00380-021-01947-3
Funding for this research was provided by:
Boston Scientific Corporation
Article History
Received: 23 July 2021
Accepted: 17 September 2021
First Online: 23 September 2021
Declarations
:
: Yoshimitsu Soga is an advisor to Boston Scientific. Masahiko Fujihara reports consulting for Boston Scientific. Yoshito Yamamoto reports no conflicts of interest. Shigeru Nakamura reports consulting for Asahi Intecc, OrbusNeich, Nipro, and Boston Scientific and receiving honoraria from Terumo, Medtronic, Medikit, Abbott. Osamu Iida reports consulting for Boston Scientific. Daizo Kawasaki reports consulting for Boston Scientific. Kazushi Urasawa reports consulting for Boston Scientific. Hiroshi Ando reports no conflicts of interest. Shinsuke Mori reports no conflicts of interest. Kenji Suzuki reports no conflicts of interest. Kazunori Horie reports no conflicts of interest. Juan Diaz-Cartelle is an employee of and owns stock in Boston Scientific. Amane Kozuki reports no relationships to disclose.